Colorado Cancer Research Program

Denver, Colorado 80224

0 studies enrolling now · 8 studies all time

What they study most

Aging, Cholangiocarcinoma, Cognition, Colonic Neoplasms, Colorectal Cancer, Colorectal Neoplasms, DCIS, Ductal Carcinoma in Situ, Gastric Cancer, Gastroesophageal Junction Cancer, Lymphoma, Non-Hodgkin, Metastatic Colorectal Cancer

Studies at this site

• Comparing an Operation to Monitoring, With or Without Endocrine Therapy (COMET) Trial For Low Risk DCIS — Running, not enrolling
• Lenalidomide Plus Rituximab Followed by Lenalidomide Versus Rituximab Maintenance for Relapsed/Refractory Follicular, Marginal Zone or Mantle Cell Lymphoma. — Completed
• A Study of BBI608 Plus Weekly Paclitaxel to Treat Gastric and Gastro-Esophageal Junction Cancer — Completed
• Morphotek Investigation in Colorectal Cancer: Research of MORAb-004 (MICRO) — Stopped early
• A Study Evaluating Regorafenib Following Completion of Standard Chemotherapy for Patients With Colon Cancer — Stopped early
• Study of Oxaliplatin/5-FU/Leucovorin Plus Vatalanib Versus Oxaliplatin/5-FU/Leucovorin in Patients With Metastatic Colorectal Cancer. — Completed
• Phase II Trial of Nab-Paclitaxel and Gemcitabine for First-Line Treatment of Patients With Cholangiocarcinoma — Completed
• Cognition in the Study of Tamoxifen and Raloxifene — Completed